Suresh S. Ramalingam, MD, FASCO Profile
Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

Followers
6K
Following
8K
Media
162
Statuses
1K

Executive Director @WinshipAtEmory | Professor @EmoryUniversity |Associate VP for Cancer, Woodruff Health Sciences Center I Opinions are my own.

Atlanta, GA
Joined July 2009
Don't wanna be here? Send us removal request.
@JournalCancer
ACS Journal Cancer
7 days
Big news: The @AmericanCancer Society Journals YouTube channel is now live! 📺 Watch author summaries, CancerSpeak podcast episodes, Editor Spotlights, and more. New videos added regularly. Subscribe: https://t.co/T1y0pmJLFm @OncoAlert @RamalingamMD
0
7
9
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
16 days
Great to have ⁦@DrFadloKhuri⁩ as a guest at the 2025 ⁦@WinshipAtEmory⁩ Scientific Symposium. ⁦@AUB_Lebanon⁩ ⁦@EmoryUniversity⁩ ⁦@AdamMarcusPhD
1
5
19
@WinshipAtEmory
Winship Cancer Institute of Emory University
16 days
This Neuroendocrine Cancer Awareness Month, we’re highlighting the experts dedicated to this rare cancer. At Winship, Daniel Halperin, MD, leads a multidisciplinary team bringing cutting-edge therapies and clinical trials to patients with NETs. ➡️ https://t.co/aHn6bJtDmd
0
2
7
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
16 days
The 2025 ⁦@WinshipAtEmory⁩ Scientific Symposium is focused on AI and Big Data. Keynote by ⁦@anantm⁩. ⁦@EmoryUniversity⁩ ⁦@AdamMarcusPhD⁩ ⁦@theNCI
0
4
15
@JournalCancer
ACS Journal Cancer
23 days
Our sister journal @CACancerJournal celebrates 75 years of publication this month! Join us in celebrating this important milestone and read reflections on CA's 75-year journey:
Tweet card summary image
acsjournals.onlinelibrary.wiley.com
Click on the article title to read more.
@CACancerJournal
CA: A Cancer Journal for Clinicians
23 days
November marks CA’s 75th anniversary. Published since 1950, CA has grown into the @AmericanCancer flagship journal, publishing trusted, authoritative information about cancer to guide clinicians & researchers worldwide. Read the commemorative editorial: https://t.co/IDjkhFTiMo
0
1
7
@BioAscend
BioAscend
1 month
The next expert panel discusses agents targeting EGFR, ALK, and KRAS G12C at #ALCS2025 including @RamalingamMD @ShirishGadgeel @JennyCarlisleMD and Drs Paul Gill and Gregory Riely.
0
1
3
@BioAscend
BioAscend
1 month
A big “thank you” from our co-chairs @RamalingamMD and @LealTiciana to everyone that attended #ALCS2025. We can't wait to see you in 2026 for the 20th Annual Atlanta Lung Cancer Symposium!
0
2
4
@BioAscend
BioAscend
1 month
We kick off #ALCS2025 with co-chairs @RamalingamMD and @LealTiciana welcoming atttendees.
0
2
6
@JournalCancer
ACS Journal Cancer
1 month
Cancer is an international, interdisciplinary journal published by @AmericanCancer and offers something for everyone in oncology: from research to clinical practice. 📗 Hear from Editor-in-Chief @RamalingamMD, then learn more: https://t.co/ScQuqaKGUe @OncoAlert #ESMO25
0
7
11
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
2 months
Important new report on invasive lobular breast cancer in the US. @JournalCancer @WinshipAtEmory @KalinskyKevin @TariKingMD @reshmajagsi @MylinTorres
@JournalCancer
ACS Journal Cancer
2 months
New @AmericanCancer report provides statistics on lobular breast cancer. Know the numbers: 🩺~11% of US breast cancers are invasive lobular carcinoma 📈 Incidence rising faster than other breast cancers 📊~33,600 diagnoses expected in 2025 https://t.co/TaWwnPO8qM @OncoAlert
2
1
11
@JournalCancer
ACS Journal Cancer
2 months
New @AmericanCancer report provides statistics on lobular breast cancer. Know the numbers: 🩺~11% of US breast cancers are invasive lobular carcinoma 📈 Incidence rising faster than other breast cancers 📊~33,600 diagnoses expected in 2025 https://t.co/TaWwnPO8qM @OncoAlert
11
22
37
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
2 months
The 15th annual ⁦@WinshipAtEmory⁩ 5K was a resounding success with >4200 participants. We exceeded our fundraising goal of $1M to support cancer research. Thanks to our patients, families, staff and researchers who made this possible. #winship5K@EmoryUniversity
2
1
15
@JournalCancer
ACS Journal Cancer
2 months
“The number of assessments for clinical trials has exploded... AI approaches can help reduce friction on the reproducible pain points.” @PatelOncology discusses the potential role of AI in clinical research in the latest CancerSpeak episode: https://t.co/UcgdctXmmD @OncoAlert
1
11
11
@BioAscend
BioAscend
3 months
🌟 Plenary Sessions Revealed at #ALCS2025🌟 Get ready for a comprehensive dive into the latest breakthroughs in lung cancer care: 🔹 Early-Stage/Locally Advanced #NSCLC: Multidisciplinary integration of neoadjuvant, surgical, & adjuvant therapies 🔹 Advanced NSCLC/SCLC 🔹
3
2
0
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
3 months
Worthy recipients of @IASLC distinguished awards! Congratulations to these amazing individuals. I am reminded of my first poster at WCLC with Dr. Dacic as co-author. @WinshipAtEmory
@StephenVLiu
Stephen V Liu, MD
3 months
Congratulations to the 2025 @IASLC, distinguished service award winners! Grateful for all the impact and happiness is the recognition at #WCLC25 for Drs. Sanja Dacic, Pasi Janne, @peters_solange and Wytold Rzyman!
8
5
38
@StephenVLiu
Stephen V Liu, MD
3 months
Congratulations to the 2025 @IASLC, distinguished service award winners! Grateful for all the impact and happiness is the recognition at #WCLC25 for Drs. Sanja Dacic, Pasi Janne, @peters_solange and Wytold Rzyman!
3
21
59
@POAUB
AUB Office of the President
3 months
Relive the highlights of the Festschrift honoring Dr. Fadlo R. Khuri. From thought-provoking panels to personal tributes, the event celebrated his enduring impact as a physician, leader, and mentor. #AUB #AUBproud
0
8
20
@WinshipAtEmory
Winship Cancer Institute of Emory University
3 months
🎉 Winship, through generous support from the @blankfoundation and in collaboration with @MountSinaiNYC, celebrated the launch of the new Winship Mobile Prostate Cancer Screening Program today at a community event. ➡️ https://t.co/okKPdqceIx #WinshipProstateCheck
9
5
9
@eaonc
ECOG-ACRIN Cancer Research Group
3 months
In our August newsletter, the co-chairs spotlight an open letter to Congress from the National Clinical Trials Network Cooperative Group Chairs, detailing its significant contributions to patient welfare. Read their editorial and the full letter here: https://t.co/YijQElKu3w
2
7
12
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
3 months
Memorable day ⁦@AUB_Lebanon⁩ at the Festschrift celebrating ⁦@DrFadloKhuri ‘s career as a scholar, mentor, leader and humanist. Joined by ⁦@wallyjc⁩ ⁦@teekayowo⁩ ⁦@DrRoyHerbstYale⁩ ⁦@AdamMarcusPhD⁩. ⁦@WinshipAtEmory⁩ ⁦@OtisBrawley
4
6
53